Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Fudan University · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
gastric-cancermetastasis
gastric cancer, metastasis, target therapy, apatinib, anti-pd-1 antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 842059
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.